HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Ephraim J. Fuchs, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 1.9k
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamideAmy E. DeZern, Robert A. Brodsky, Marianna Zahurak et al.|Blood Advances|2020Cited by 149
Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation with High Dose, Post-Transplantation CyclophosphamideAshley Munchel, Ephraim J. Fuchs, Chimen Kesserwan et al.|Pediatric Reports|2011Cited by 84
Blinatumomab in Combination with Immune Checkpoint Inhibitors of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Preliminary Results of a Phase I StudyJonathan Webster, Ivana Gojo, Daniel J. DeAngelo et al.|Blood|2018Cited by 50
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemiaAmy E. DeZern, Robert A. Brodsky, Marianna Zahurak et al.|Blood|2023Cited by 41